In estrogen receptor (ER) positive breast cancer, ER and NF-κB worked together to upregulate PHLDA1 expression directly through enhanced transcription and indirectly through repression of miR-181a and miR-181b [7]. This evidence concerns the gene ESR1 and breast cancer.